Grifols

Grifols EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Grifols (GRF.MC) as of Nov 2, 2026 is 5.45. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 5.80 — a change of -6.14% (lower).

EV/EBIT

5.45

YoY

-6.14%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Grifols is 2025 5.45 . EV/EBIT (Enterprise Value to EBIT) of Grifols was 2024 5.80 . It decreases by -6.14% lower compared to the previous year.

The Grifols EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
5.82 EUR
Jan 1, 2020
6.67 EUR
Jan 1, 2021
11.17 EUR
Jan 1, 2022
8.25 EUR
Jan 1, 2023
9.01 EUR
Jan 1, 2024
5.80 EUR
Jan 1, 2025
5.45 EUR
Jan 1, 2026 (e)
5.53 EUR
The Grifols EV/EBIT history
YEAREV/EBITYoY
est5.53+1.51%
5.45-6.14%
5.80-35.56%
9.01+9.18%
8.25-26.14%
11.17+67.40%
6.67+14.59%
5.82-12.91%
6.69-1.93%
6.82-3.65%
7.08+3.30%
6.85-11.61%
7.75-51.29%
15.91+18.82%
13.39-10.79%
15.01+39.76%
10.74-17.57%
13.03-11.72%
14.76-42.77%
25.79+19.45%
21.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grifols Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Grifols's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Grifols's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Grifols's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Grifols grows earnings faster than its peers.

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

EV/EBIT (Enterprise Value to EBIT) of Grifols is 5.45 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Grifols changed from 5.80 to 5.45, representing a -6.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Grifols since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Grifols with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Grifols

All Key Metrics — Grifols